SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2017 / Cilt: 28 - Sayı: 1

When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?

Altay ÇELEBİ
Hasan YILMAZ
Pages
68–70
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we reviewed potential risks of concomittant use of PPIs and other drugs and apropriate PPI choise

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Currently, proton pump inhibitors (PPIs) are widely used either over the counter or on prescription drugs.
📊
Key Findings & Data:PPI’s are frequently used with other drugs when elderly and chronic desease burden population is taken to consideration.
💡
Conclusion & Impact:In this study, we reviewed potential risks of concomittant use of PPIs and other drugs and apropriate PPI choise
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Currently, proton pump inhibitors (PPIs) are widely used either over the counter or on prescription drugs. PPI’s are frequently used with other drugs when elderly and chronic desease burden population is taken to consideration. Drug interactions with PPIs are a prominent clinical problem in this direction. In this study, we reviewed potential risks of concomittant use of PPIs and other drugs and apropriate PPI choise

🔖

Cite This Article

ÇELEBİ, A., YILMAZ, H. (2017). When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 1, 68–70. https://ajindex.com/articles/410203

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Huang B, Huang Y, Li Y, et al. Adverse cardiovascular effects of concomitant use of proton pump inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-analysis. Arch Med Res 2012
  2. [CrossRef] 2. Siller-Matula JM, Jilma B, Schrör K, Christ G, Huber K. Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb Haemost 2010
  3. [CrossRef] 3. Pan WJ, Goldwater DR, Zhang Y, Pilmer BL, Hunt RH. Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline. Aliment Pharmacol Ther 2000
  4. [CrossRef] 4. Dilger K, Zheng Z, Klotz U. Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline. Br J Clin Pharmacol 1999
  5. [CrossRef] 5. Humphries TJ, Nardi RV, Spera AC, et al. Coadministration of rabeprazole sodium (E3810) does not affect the pharmacokinetics of anhydrous theophylline or warfarin. Gastroenterology 1996
  6. A138. 6. Duursema L, Müller FO, Schall R, et al. Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin [see comments]. Br J Clin Pharmacol 1995
  7. [CrossRef] 7. Sutfin T, Balmer K, Boström H, Eriksson S, Höglund P, Paulsen O. Stereoselective interaction of omeprazole with warfarin in healthy men. Ther Drug Monit 1989
  8. [CrossRef] 8. Hartmann M, Huber R, Bliesath H, et al. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. Int J Clin Pharmacol Ther 1996
  9. 34(Suppl 1): S67-71. 9. Le GH, Schaefer MG, Plowman BK, et al. Assessment of potential digoxin--rabeprazole interaction after formulary conversion of proton-pump inhibitors. Am J Health Syst Pharm 2003
  10. Oosterhuis B, Jonkman JH, Andersson T, Zuiderwijk PB, Jedema JN. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose. Br J Clin Pharmacol 1991
  11. [CrossRef] 11. Adamopoulos AB, Sakizlis GN, Nasothimiou EG, et al. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study. J Cardiovasc Pharmacol 2009
  12. [CrossRef] 12. Andersson T, Morrison D, Nagy P, Pisupati J, Schettler J, Warner TD. Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers. Am J Cardiovasc Drugs 2012
  13. [CrossRef] 13. Off